Axial Therapeutics is a clinical-stage biopharmaceutical company focused on discovering & developing gut-restricted, small molecule therapeutics for CNS disorders. Leveraging expertise in gut-brain axis & unique drug dev platform, we aim to advance novel therapies with transformative potential in ne...See more
Headquarter United States of America |
Countries of operation Australia, United States of America |
Year founded 2016 (8 years) |
Funding status Series C |
Company type SME |
Non Executive Director